Kindred Biosciences Inc
|Market Cap (Intraday)||414.16M|
|2yr Forward PE||N/A|
Kindred Biosciences Inc Stock, NASDAQ:KIN
Kindred Biosciences, Inc. is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA.